Anbio Biotechnology
NASDAQ:NNNN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.67
52.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Bankruptcy Probability
Anbio Biotechnology's probability of bankruptcy is 1.4%, making a collapse highly unlikely. The solvency score is 70/100 — a strong indicator of financial stability.
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Financial Position
A solvent company is one that owns more than it owes. Comparing the amount of cash and investments with existing debt gives an idea of the company's long-term financial health.
| Dec 31, 2024 | 11.8m |
| Jun 30, 2024 | 10.3m |
| Dec 31, 2024 | 0 |
| Jun 30, 2024 | 0 |
| Dec 31, 2024 | 0 |
| Jun 30, 2024 | 0 |
Interest Coverage
To determine how easily a company can pay interest on its outstanding debt, the Interest Coverage ratio is used. It represents how many times the company can pay its obligations using its operating income.
The lower the ratio, the more the company is burdened by debt expenses. When a company's interest coverage ratio is only 1.5 or lower, its ability to meet interest expenses may be questionable.
| Dec 31, 2024 | 2m |
| Jun 30, 2024 | 5.6m |
| Dec 31, 2024 | |
| Jun 30, 2024 |
| Dec 31, 2024 | |
| Jun 30, 2024 |
All Solvency Ratios
Other solvency & liquidity ratios which help to assess the company’s capacity to stay afloat.
| Dec 31, 2024 | 0 |
| Jun 30, 2024 | 0 |
| Dec 31, 2024 | 0.0914 |
| Jun 30, 2024 | 0.0279 |
| Dec 31, 2024 | 6.7974 |
| Jun 30, 2024 | 19.5347 |
| Dec 31, 2024 | 6.7974 |
| Jun 30, 2024 | 19.5347 |
| Dec 31, 2024 | 10.7122 |
| Jun 30, 2024 | 35.5553 |
| Dec 31, 2024 | 2.3711 |
| Jun 30, 2024 | 3.4935 |
Anbio Biotechnology's probability of bankruptcy is 1.4%, making a collapse highly unlikely.
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Anbio Biotechnology has no debt.
You can find a full breakdown on its Balance Sheet.
